Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Labcorp acquires assets of BioReference Health, and Agilent is buying the digital pathology software provider Proscia.
By: Patrick Lavery
Editor’s Take: More acquisitions were just the most attention-grabbing headlines in a varied and busy week in pharma.
This week in “The Friday Brief” … Big money moving in acquisitions. Labcorp reached agreement with OPKO Health to acquire assets of BioReference Health. Taking on this lab testing business comes at a price tag of $722 million.
Agilent is acquiring Proscia for $270 million; Proscia provides digital pathology software for clinical and life sciences customers.
Meanwhile in partnerships … Vir Biotechnology struck a deal with Gilead to discover and engineer T-cell engager development candidates. Scinai Biopharma has a development and clinical manufacturing agreement with a U.S.-based biopharma company. This is for an investigational oncology product, and expands a previously disclosed engagement.
Lonza reached a deal with Qurient to use CDK7 inhibitors in dual-payload ADC applications. Lonza also announced it is expanding its accelerated DNA-to-IND offering beyond monoclonal antibodies.
Catalent announced a commercial supply agreement with Mantra, to provide CDMO services for Mantra’s oral gel product platform. Charles River Labs says it will support Magellan Stem Cells in development and clinical advancement of stem cell-based therapies.
AtomVie Radiopharma and Jubilant Radiopharma are teaming up on logistics, regulatory, and last-mile distribution for a portfolio of radiopharmaceutical programs. In AI news, Deep Origin and BioAge Labs are coming together on multi-target, AI-driven drug discovery. The two sides say this partnership has already achieved an initial milestone.
And IQVIA is expanding its partnership with Veeva Systems, selecting several Veeva applications to be deployed across clinical development studies.
A few last items to wrap up. GSK is investing more than $800 million to expand facilities in Montgomery County, Pa. CurTec invested $10 million to expand operations in Westminster, SC. And UCB dedicated the future site of its U.S. biologics manufacturing campus in Gwinnett County, Ga.
We have more for you to read about this week’s wheelings and dealings at contractpharma.com. Also, don’t forget to sign up for our newsletters so you get the latest delivered directly to you.
We’ll see you back here next week, on The Friday Brief.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !